| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
yna Nowak,1Departments of 1Pharmaceutical Sciences and 2Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205; and 3Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425
Submitted 20 June 2002 ; accepted in final form 7 May 2003
The lack of cyclin-dependent kinase inhibitor p21WAF1/CIP1 (p21) in mice increases renal proximal tubular cell death and enhances sensitivity to acute renal failure produced by the chemotherapeutic agent cisplatin. We used primary cultures of mouse renal proximal tubular cells (MPTC) grown in optimized culture conditions to investigate the cellular basis for increased apoptosis in p21 knockout mice. Cisplatin (15 µM) activated caspase-3 but not caspase-8 or caspase-9 and produced phosphatidylserine externalization, chromatin condensation, and nuclear fragmentation in wild-type [p21(+/+)] MPTC. Caspase-3 activation and apoptosis were accelerated in cisplatin-treated MPTC lacking p21 [p21(-/-) MPTC]. In contrast to p21(+/+) MPTC, cisplatin activated caspase-9 but not caspase-8 in p21(-/-) MPTC before caspase-3 activation. The caspase-3 inhibitor Asp-Glu-Val-Asp-fluoromethylketone (DEVD-fmk) inhibited caspase-3 activity but did not abolish apoptosis in p21(+/+) and p21(-/-) MPTC. General caspase inhibitor Z-Val-Ala-Asp(OCH3)-fluoromethylketone (ZVAD-fmk) inhibited caspase activity and decreased chromatin condensation by 51% in p21(-/-) but not in p21(+/+) MPTC. However, cisplatin-induced phosphatidylserine externalization was not inhibited by ZVAD-fmk in p21(-/-) MPTC. We conclude that 1) in the presence of p21, cisplatin activates caspase-3 through a mechanism independent of caspase-8 or caspase-9; 2) in the absence of p21, caspase-9 activation precedes caspase-3 activation; 3) the lack of p21 accelerates caspase-3 activation and cisplatin-induced MPTC apoptosis; and 4) MPTC apoptosis is caspase independent in the presence of p21 but partially dependent on caspases in the absence of p21.
renal proximal tubular cells; caspase activation; DNA damage; knockout mice
This article has been cited by other articles:
|
|
 |
|
  M. Jiang and Z. Dong Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nowak, G. L. Clifton, and D. Bakajsova Succinate Ameliorates Energy Deficits and Prevents Dysfunction of Complex I in Injured Renal Proximal Tubular Cells J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1155 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mazzinghi, E. Ronconi, E. Lazzeri, C. Sagrinati, L. Ballerini, M. L. Angelotti, E. Parente, R. Mancina, G. S. Netti, F. Becherucci, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cells J. Exp. Med., February 18, 2008; 205(2): 479 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. P. Shaik, E. K. Fifer, and G. Nowak Protein kinase B/Akt modulates nephrotoxicant-induced necrosis in renal cells Am J Physiol Renal Physiol, January 1, 2007; 292(1): F292 - F303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nowak, G. L. Clifton, M. L. Godwin, and D. Bakajsova Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells Am J Physiol Renal Physiol, October 1, 2006; 291(4): F840 - F855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Lee and H. J. Han Role of ATP in DNA synthesis of renal proximal tubule cells: involvement of calcium, MAPKs, and CDKs Am J Physiol Renal Physiol, July 1, 2006; 291(1): F98 - F106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhou, Y. Fujigaki, A. Kato, T. Miyaji, H. Yasuda, T. Tsuji, T. Yamamoto, K. Yonemura, and A. Hishida Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats Am J Physiol Renal Physiol, July 1, 2006; 291(1): F225 - F235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Nath Provenance of the protective property of p21 Am J Physiol Renal Physiol, September 1, 2005; 289(3): F512 - F513. [Full Text] [PDF]
|
|
|
|
|
|
F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price Identification of the functional domain of p21WAF1/CIP1 that protects cells from cisplatin cytotoxicity Am J Physiol Renal Physiol, September 1, 2005; 289(3): F514 - F520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Basnakian, E. O. Apostolov, X. Yin, M. Napirei, H. G. Mannherz, and S. V. Shah Cisplatin Nephrotoxicity Is Mediated by Deoxyribonuclease I J. Am. Soc. Nephrol., March 1, 2005; 16(3): 697 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Wu, L. L. Muldoon, and E. A. Neuwelt The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis through Caspase Signaling Pathway J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 424 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jiang, X. Yi, S. Hsu, C.-Y. Wang, and Z. Dong Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1140 - F1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Price, R. L. Safirstein, and J. Megyesi Protection of renal cells from cisplatin toxicity by cell cycle inhibitors Am J Physiol Renal Physiol, February 1, 2004; 286(2): F378 - F384. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
